Results 281 to 290 of about 108,551 (297)

NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death

Proceedings of the National Academy of Sciences of the United States of America, 2018
Hans-Guido Wendel, Anas Younes, Patrizia Mondello   +2 more
exaly  

BCL2

1997
openaire   +1 more source

Prognostic influence of BCL2 expression in breast cancer

International Journal of Cancer, 2012
Ki-Tae Hwang, Wonshik Han, Dong-Young Noh   +2 more
exaly  

Bcl2 family proteins in carcinogenesis and the treatment of cancer

Apoptosis: an International Journal on Programmed Cell Death, 2009
Andreas Villunger, Francesca Grespi
exaly  

IBCL-554 Outcomes of BCL2-R+ and BCL2-RFollicular Lymphoma Treatment

Clinical Lymphoma Myeloma and Leukemia
Ekaterina Nesterova, Evgeniy Zvonkov, Alla Kovrigina, Tatiana Obukhova, Yana Mangasarova, Hunan Julhakyan, Sergey Kulikov, Elena Parovichnikova   +7 more
openaire   +1 more source

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma Free

Blood, 2013
Michael Hummel, Wolfram Klapper, German Ott   +2 more
exaly  

BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial

Annals of Oncology, 2017
Thierry J Molina, Marie Parrens, Karen Leroy   +2 more
exaly  

BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations

British Journal of Haematology, 2009
David Y Mason, T Andrew Lister
exaly  

Different forms of cell death induced by putative BCL2 inhibitors

Cell Death and Differentiation, 2009
Ingo Schmitz, Klaus Schulze-Osthoff, Kathrin Weber   +2 more
exaly  

The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-“negative” grade 1/2 follicular lymphomas

Human Pathology, 2013
Leticia Quintanilla-Martínez de Fend, Katja Weisel, Falko Fend   +2 more
exaly